Skip to main content
Clinical Trials/NCT02991092
NCT02991092
Unknown
Not Applicable

The Influence of Different Fluid Therapy Measures on the Postoperative Outcome in Fast Track of Colon Cancer After Laparoscopic Surgery.

Quan Wang0 sites150 target enrollmentNovember 2016
ConditionsColon Carcinoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colon Carcinoma
Sponsor
Quan Wang
Enrollment
150
Primary Endpoint
recovery time of intestinal function
Last Updated
9 years ago

Overview

Brief Summary

To compare the influence of two different fluid administration strategies on the clinical efficacy of patients with colorectal carcinoma during the fast-track surgery.

Detailed Description

Patients that were diagnosed with colorectal carcinoma by the First Hospital of Jilin University and were scheduled to undergo the laparoscopic surgery were prospectively included and divided into the experimental group and the control group with the random number method. After surgery, patients in the experiment group were provided with intravenous fluid administration at 1.0ml/Kg/h and encouraged to take food and drink water early after surgery, and the intravenous fluid administration was stopped immediately when the oral intake was more than 1500ml/h; patients in the control group strictly followed the fasting and were provided with the intravenous fluid administration according to "Total amount of fluid = physiological requirement + additional loss (fever + gastrointestinal decompression) + amount lost" until their intestinal function completely recovered. The blood volume change indicators (heart rate, mean arterial pressure, oxyhemoglobin saturation, inferior vena cava diameter /body surface area (VCD), intra-abdominal pressure, specific gravity of urine, BNP, etc.) and inflammation indicators (CRP, IL-6, TNF-a) of the two groups of patients were observed and a comparison was made of the recovery time of intestinal function, incidence of complications, hospitalization time after operation and hospitalization expenses of the two groups.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
May 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Quan Wang
Responsible Party
Sponsor Investigator
Principal Investigator

Quan Wang

Deputy chief physician

The First Hospital of Jilin University

Eligibility Criteria

Inclusion Criteria

  • the age of 18-70 years old
  • the pathological diagnosis of colon cancer patients
  • no surgical intervention.

Exclusion Criteria

  • patients with heart, lung, liver, renal function were significantly abnormal
  • body mass index kg \>35 / m2
  • sepsis or systemic inflammatory response syndrome patients.
  • patients with severe malnutrition.

Outcomes

Primary Outcomes

recovery time of intestinal function

Time Frame: within the first 30 days (plus or minus 3 days) after surgery

Secondary Outcomes

  • CRP[=C reactive protein]ba(the first day to the forth day After the operation)
  • IL-10[=interleukin-10](the first day to the forth day After the operation)
  • BNP[=type B natriuretic peptide](the first day to the forth day After the operation)
  • hospitalization time after operation(day)(within the first 30 days (plus or minus 3 days) after surgery)
  • TNF-alpha(the first day to the forth day After the operation)

Similar Trials